Dossier
Indian drugmakers
Coverage of Indian drugmakers in the Nexus archive.
- STAT+: Pharmalittle: We’re reading about Trump’s plan for tariffs on generics, a Merck and Gilead HIV pill, and more
President Trump plans to impose 100% tariffs on imported generic medicines starting in August 2028, increasing to 200% in 2029, aiming to bring pharmaceutical manufacturing to the U.S. Critics warn this could raise drug costs, cause shortages, and disrupt supply chains. Indian drugmakers, a major U.S. generic drug supplier, have been unsettled by the proposal.